Jiangsu Expressway (00177) approved a pro rata capital increase in Jiangsu Danjin Expressway Co., Ltd. (Danjin Company), a subsidiary responsible for the Danyang to Jintan Section of the Fuli Expressway project. The total capital injection into Danjin Company is RMB3,534,265,840, with Jiangsu Expressway contributing RMB2,636,555,840 and Changzhou Transportation Holdings Group Co., Ltd. contributing RMB897,710,000.

According to the announcement, Danjin Company’s registered capital will rise from RMB1,704,000,000 to RMB5,238,265,840. Jiangsu Expressway continues to hold a 74.5998% equity interest in Danjin Company, and Changzhou Transportation Holdings retains 25.4002%. Post-injection, there is no change in consolidation scope for Jiangsu Expressway.

The capital increase is intended to support ongoing construction of the Danyang to Jintan Section of the Fuli Expressway. Directors confirm that the agreement is on normal commercial terms and will not adversely affect the company’s financial position or operating performance. Under Hong Kong Listing Rules, the transaction is deemed a connected transaction but is fully exempt; under Shanghai Stock Exchange rules, it is a discloseable transaction without shareholder approval requirements.